The stem cell assay market has witnessed substantial growth, driven by advancements in stem cell research, increasing investments in healthcare innovation, and the rising demand for regenerative medicine. The global market for stem cell assays was valued at USD 6.4 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 13.18% from 2025 to 2034, reaching an estimated...